# Debate Transcript

## Advocate — round 1

# Argument for Acceptance

The specialist reviews converge on a consistent picture: this is a method-development paper with a genuinely novel procedural contribution, an admirably transparent dataset, and statistical limitations that are real but addressable. The case for acceptance rests on three pillars.

**First, the core methodological contribution is novel and defensible.** The novelty reviewer's audit confirms that "the specific contribution of gigaseal-preserved retrieval with capacitance-yield correlation is not preempted by anything I found." The framework of categorizing retrieval outcomes and analyzing all samples indiscriminately—rather than discarding "failed" patches—is a genuine delta over the field's standard all-or-nothing practice, which the literature reviewer confirms is accurately characterized in prior work (refs 7–9). The ethics reviewer finds the work fully compliant, and the data deposition (MassIVE, ProteomeXchange, Zenodo videos) is exemplary.

**Second, the statistical criticisms, while valid, are criticisms of overstatement, not of the underlying observation.** The n=3 capacitance correlation is fragile—the data-analysis reviewer is right that R²=0.998 with three points is not evidence of a robust relationship. But the authors *do* hedge in the abstract ("tended to be associated") and the conclusions explicitly frame this as a proof-of-concept. The fix is not more data; it is recalibration of language. The rigor reviewer's own analysis shows the most defensible claim—that retrieval loss decouples proteomics from electrophysiology—is supported by the torn-neuron data. The manuscript's value is the framework, not the specific p-values.

**Third, the weaknesses are revision-level, not rejection-level.** The methodology reviewer's demand for matched controls (same neuron type, different retrieval outcomes) is a reasonable *next study*, not a prerequisite for publishing a framework proposal. The reproducibility reviewer's requests—specific GitHub repo, DIA-NN parameters, SynGO settings—are all straightforward additions. The one genuinely concerning item is the literature reviewer's finding of an uncited, unrelated reference (ref 31, saxitoxin synthesis), which is a citation-hygiene error that can be corrected in revision.

This is exactly the kind of paper In Silico exists to publish: a methodologically interesting, honestly reported, small-scale study whose claims can be evaluated and whose limitations are stated. Accept with revisions.

## Skeptic — round 1

# Skeptic's Opening Statement

The advocate's case rests on a false equivalence: that "overstatement" is a cosmetic flaw when it is actually the load-bearing wall of this manuscript. The central claims are not merely phrased too strongly—they are untested at the sample sizes provided.

**The n=3 correlation is not a language problem; it is the entire quantitative foundation.** The abstract states "Protein identifications correlated with log-transformed capacitance," and the Results section calls this "linking soma size to proteome yield." The data-analysis reviewer is unambiguous: "The reported p-value (p<0.05) is not meaningful with such a small sample size, and the adjusted R² of 0.998 is a statistical artifact of overfitting." The rigor reviewer concurs: "The claim as worded... is HARD unsupported." This is not a hedge the authors can fix by softening "demonstrate" to "suggest"—the claim itself, as a *finding*, does not survive contact with the evidence. The advocate says "the fix is not more data; it is recalibration of language." But recalibration of language *is* the admission that the finding is not established. That is a rejection-level concession, not a revision-level one.

**The qualitative claim about spike integrity and synaptic enrichment is confounded by the authors' own variable.** The rigor reviewer identifies the fatal flaw: neuron #6, the "compromised spiking" case, was also the smallest neuron by capacitance. The authors themselves show capacitance correlates with yield. The claim that "preservation of active properties... is associated with recovery of synaptic proteins" cannot be separated from "larger neurons yield more proteins." The methodology reviewer's demand for matched controls is not a "next study"—it is the minimum design needed to make the claim at all. Without it, the paper's headline finding is an anecdote with a confound.

**The "shotgun" framework's value is asserted, not demonstrated.** The novelty reviewer notes the authors never compare their indiscriminate-collection strategy against a threshold-based exclusion approach. The PCA separation of torn neurons is descriptive; no PERMANOVA or cluster-stability metric is reported. The claim that this framework "enables systematic evaluation of retrieval quality" is a proposal, not a demonstrated capability.

**The most defensible claim—that retrieval loss decouples proteomics from electrophysiology—is also the most obvious.** Of course a torn neuron yields fewer proteins. The rigor reviewer correctly labels this "the most obvious" claim in the paper. A framework built on the unsurprising is not enough to carry the overreaching claims built on top of it.

The advocate's strongest point is the novelty: gigaseal-preserved retrieval with capacitance-yield correlation is genuinely new. But novelty without evidentiary support is a proposal, not a finding. This manuscript should be rejected—or, at minimum, sent back for the authors to either (a) substantially expand the dataset or (b) explicitly reframe the paper as a methodological proposal with illustrative observations, stripping the correlational and associative claims from the abstract and conclusions.